Stroke Treatment With Acute Reperfusion and Simvastatin

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to determine whether simvastatin treatment started within the first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at seventh day/discharge or at the third month. Also, to demonstrate that simvastatin is safe and not associated with higher rates of hemorrhagic transformation in patients who receive thrombolysis.
Epistemonikos ID: 3694e47c075c5be0c3533b55bc4ad190ead3510a
First added on: May 05, 2024